2m 2m 2m 2m 2m 2m 2m
Evaxion Sp ADS (EVAX)
NASDAQ
$3.40+$0.010 (+0.29%)
Price as of Jun 23, 2026 4:34 PM EDT- $28.5MMarket Cap
- 40.16%1-Year Change
- BiotechnologyIndustry
Evaxion Sp ADS (EVAX)
$3.40+$0.010 (+0.29%)
EVAX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $3.39 | ||
Change | +$0.37 (+12.13%) | ||
Open | $3.40 | ||
High | $3.60 | ||
Low | $3.38 | ||
Previous Close | $3.42 | ||
Volume | 11,474 | ||
30-Day Average Volume | 34,710 | ||
1-Week Change | -5.00% | ||
1-Month Change | -16.18% | ||
1-Year Change | 40.16% | ||
3-Year Change | -94.48% | ||
5-Year Change | -98.88% | ||
Fundamentals | |||
Shares Outstanding | 8.3M | ||
Total Assets | $28.4M | ||
Market Cap | $28.5M | ||
Enterprise Value | $5.3M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | N/A | ||
Free Cash Flow | N/A | ||
EBIT | N/A | ||
EBITDA | N/A | ||
Net Working Capital | N/A | ||
EPS | N/A | ||
Enterprise Value/EBITDA | N/A | ||
Enterprise Value/Revenue | N/A | ||
P/B | N/A | ||
P/E | N/A | ||
PEG | N/A | ||
Price/Free Cash Flow | N/A | ||
Price/Operating Cash Flow | N/A | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 5 | ||
Last Split Date | 01/14/2025 | ||
Earnings & Revenue